Title:
【発明の名称】ヒト前立腺癌関連遺伝子配列およびポリペプチド
Document Type and Number:
Japanese Patent JP2003512816
Kind Code:
A
Abstract:
The present invention relates to novel pancreatic related polynucleotides, the polypeptides encoded by these polynucleotides herein collectively referred to as "pancreatic antigens," and antibodies that immunospecifically bind these polypeptides, and the use of such pancreatic polynucleotides, antigens, and antibodies for detecting, treating, preventing and/or prognosing disorders of the pancreas, including, but not limited to, the presence of pancreatic cancer and pancreatic cancer metastases. More specifically, isolated pancreatic nucleic acid molecules are provided encoding novel pancreatic polypeptides. Novel pancreatic polypeptides and antibodies that bind to these polypeptides are provided. Also provided are vectors, host cells, and recombinant and synthetic methods for producing human pancreatic polynucleotides, polypeptides, and/or antibodies. The invention further relates to diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to the pancreas, including pancreatic cancer, and therapeutic methods for treating such disorders. The invention further relates to screening methods for identifying agonists and antagonists of polynucleotides and polypeptides of the invention. The invention further relates to methods and/or compositions for inhibiting or promoting the production and/or function of the polypeptides of the invention.
Inventors:
Rosen, Craig A.
Reuben, Stephen M.
Reuben, Stephen M.
Application Number:
JP2000605602A
Publication Date:
April 08, 2003
Filing Date:
March 08, 2000
Export Citation:
Assignee:
Human Genome Sciences, Inc.
International Classes:
G01N33/50; A61K31/7088; A61K31/711; A61K35/76; A61K38/00; A61K39/395; A61K45/00; A61K48/00; A61P1/18; A61P9/00; A61P9/06; A61P9/10; A61P9/12; A61P13/08; A61P17/02; A61P25/00; A61P25/06; A61P27/02; A61P29/00; A61P35/00; C07K14/47; C07K14/82; C07K16/18; C07K16/32; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/12; C12P21/00; C12P21/02; C12P21/08; C12Q1/02; C12Q1/68; G01N33/15; G01N33/53; G01N33/531; G01N33/566; G01N33/574; G01N33/577; G01N33/68; G01N37/00; A61K39/00; (IPC1-7): C12N15/09; A61K38/00; A61K48/00; A61P13/08; A61P35/00; C07K14/82; C07K16/32; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; C12Q1/68; G01N33/15; G01N33/50
Attorney, Agent or Firm:
Shusaku Yamamoto